Chemo-biological evaluation of antidiabetic activity of Mentha arvensis L. and its role in inhibition of advanced glycation end products

ABSTRACT

Background: There has been enormous curiosity in the development of alternative plant based medicinesto control diabetes, oxidative stress and related disorders. One of the therapeutic approaches is to reducepostprandial release of glucose in the blood. Two key enzymes that are involved in reducing postprandialglucose are a-amylase and a-glucosidase. Mentha arvensis L. has been traditionally used by several tribesas a medicinal plant to treat various disorders.Objective: The present study was undertaken to test M. arvenisis L. for inhibition of postprandialhyperglycemia.Material and method: We performed various in vitro and in vivo tests to evaluate efficacy of M. arvenisis L.for antidiabetic activity (postprandial hyperglycemia).Results: Methanolic extract of M. arvensis L. leaves showed DPPH free radical scavenging activity (morethan 78% mg/ml) and high antiglycation potential (more than 90% inhibition of AGE formation). Methanolic extract also showed remarkable inhibitory effects on a-amylase (more than 50% mg/ml) and aglucosidase (68% mg/ml) and significant inhibition of postprandial hyperglycemia in starch induced diabetic Wistar rats.Conclusion: The non-insulin dependent antidiabetic or inhibition of postprandial hyperglycemic activityof methanolic extract of M. arvensis L. leaves was shown by using in vitro and in vivo approaches in thepresent study.© 2018 Transdisciplinary University, Bangalore and World Ayurveda Foundation. Publishing Services byElsevier B.V. This is an open access article under the CC BY-NC-ND license (http//creativecommons.org/licenses/by-nc-nd/4.0/).